The expression of PD-1 was significantly higher in the patients with positive lymph node metastasis than in patients with negative lymph node metastasis (68.75% vs. 22.05%, P < 0.001). This evidence concerns the gene RPL17 and metastatic malignant neoplasm in the lymph nodes.